Showing results (1-10 of 101) with videos related to
Sort By:
Pageof 11
Expert Opinion on Investigational Drugs|July 5, 2005
Meningococcal vaccine development: a novel approachP C Fusco, M S Blake, F MichonThe Journal of Infectious Diseases|February 1, 1997
Preclinical evaluation of a novel group B meningococcal conjugate vaccine that elicits bactericidal activity in both mice and nonhuman primatesP C Fusco, F Michon, J Y Tai, et al.Vaccine|October 31, 1998
Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccineP C Fusco, F Michon, M Laude-Sharp, et al.Developments in Biologicals|February 24, 2001
Structure activity studies on group C meningococcal polysaccharide-protein conjugate vaccines: effect of O-acetylation on the nature of the protective epitopeF Michon, C H Huang, E K Farley, et al.Vaccine|October 21, 1998
Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier proteinF Michon, P C Fusco, C A Minetti, et al.Advances in Experimental Medicine and Biology|January 1, 1997
Phagocytic, serological, and protective properties of streptococcal group A carbohydrate antibodiesJ B Zabriskie, T Poon-King, M S Blake, et al.Vaccine|November 5, 1999
Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adultsP Richmond, D Goldblatt, P C Fusco, et al.The Journal of Infectious Diseases|August 7, 1999
The role of B/T costimulatory signals in the immunopotentiating activity of neisserial porinF G Mackinnon, Y Ho, M S Blake, et al.Canadian Journal of Biochemistry|May 1, 1982
Chromium trioxide oxidation of acetylated 3-amino-3,6-dideoxy-L-hexosidesJ H Banoub, F MichonJournal of Immunology (Baltimore, Md. : 1950)|April 1, 1985
Determinant specificities of the groups B and C polysaccharides of Neisseria meningitidisH J Jennings, R Roy, F MichonPageof 11